July 22, 2025

India has become a focal point in the global competition to create cutting-edge weight-loss medications. The country's pharmaceutical industry is making significant strides in developing groundbreaking drugs, with a particular emphasis on GLP1-based treatments. Companies in India are actively working on innovative drugs like Mounjaro and Wegovy, both of which incorporate the compound Semaglutide. These drugs have shown promising results in clinical trials, presenting a potential game-changer in the battle against obesity. India's pharmaceutical sector's commitment to research and development in this field is notable, especially at a time when patents for several traditional obesity treatments are nearing expiration. This shift has positioned India as a key player in the weight-loss drug market, with the potential to lead the way in providing effective solutions for obesity worldwide.

Read More at Economictimes →

Tags: Weight loss, India, Glp1, Obesity, Drugs,